Alamar Biosciences says Emory study using its NULISA platform found 10-protein blood signature identifying ALS with 98.3% accuracy

Alamar Biosciences says an Emory University study using its NULISA platform, published in Nature Communications, found a 10-protein blood signature distinguishing ALS patients from healthy controls with 98.3% balanced accuracy in an independent validation cohort, noting it is not a clinical test.

Detected & updated continuously · Source: Nebula